Add to ORKGThe high cost of many new medicines calls into question whether people in low- and middle-income countries will have access to them,1 yet an increasing number of pivotal trials are carried out in these countries. Pivotal clinical trials are thos
BACKGROUND: High cancer mortality rates in low- and middle-income countries (LMICs) have raised conc...
Despite their potential to prevent or delay the onset and progression of cardiovascular disease (CVD...
Background: Access to medicines is one of the major challenges in health policy. The high out-of-poc...
BACKGROUND: More alternatives have become available for the diagnosis and treatment of cancer in low...
Access to Innovative Medicines in a Middle-Income Country. The Case of Mexico and Cancer Medicines D...
Background There are concerns that high prices of cancer medicines may limit patient access. Since i...
Access to medicines is a problem of serious implication for the poorest countries in the world. Alth...
Access to Innovative Medicines in a Middle-Income Country. The Case of Mexico and Cancer MedicinesDa...
Background: Cancer has become the third cause of death in Mexico. Treatment for cancer is often comp...
BACKGROUND: The global burden of disease from cancer is rapidly increasing, especially in low- and ...
Objectives: While it is generally understood that large sections of the population in low- and middl...
_Background:_ Increasing attention is being paid to the affordability of medicines in low- and middl...
The adoption and prescription of new cancer drugs, and the linked expenditures are rising very fast ...
Increasing attention is being paid to the affordability of medicines in low- and middle-income count...
Thesis (Master's)--University of Washington, 2022Background: Access to safe, effective, and quality ...
BACKGROUND: High cancer mortality rates in low- and middle-income countries (LMICs) have raised conc...
Despite their potential to prevent or delay the onset and progression of cardiovascular disease (CVD...
Background: Access to medicines is one of the major challenges in health policy. The high out-of-poc...
BACKGROUND: More alternatives have become available for the diagnosis and treatment of cancer in low...
Access to Innovative Medicines in a Middle-Income Country. The Case of Mexico and Cancer Medicines D...
Background There are concerns that high prices of cancer medicines may limit patient access. Since i...
Access to medicines is a problem of serious implication for the poorest countries in the world. Alth...
Access to Innovative Medicines in a Middle-Income Country. The Case of Mexico and Cancer MedicinesDa...
Background: Cancer has become the third cause of death in Mexico. Treatment for cancer is often comp...
BACKGROUND: The global burden of disease from cancer is rapidly increasing, especially in low- and ...
Objectives: While it is generally understood that large sections of the population in low- and middl...
_Background:_ Increasing attention is being paid to the affordability of medicines in low- and middl...
The adoption and prescription of new cancer drugs, and the linked expenditures are rising very fast ...
Increasing attention is being paid to the affordability of medicines in low- and middle-income count...
Thesis (Master's)--University of Washington, 2022Background: Access to safe, effective, and quality ...
BACKGROUND: High cancer mortality rates in low- and middle-income countries (LMICs) have raised conc...
Despite their potential to prevent or delay the onset and progression of cardiovascular disease (CVD...
Background: Access to medicines is one of the major challenges in health policy. The high out-of-poc...